US 5,994,619 Β· Granted 1999-11-30
Production of chimeric bovine or porcine animals using cultured inner cell mass cells
Novel cultured inner cell mass (CICM) cells, and cell lines, derived from ungulates, in particular, pigs and cows, and methods for their preparation are provided. The subject CICMs possess similar morphology and express cell markers identically or substantially similarly to ICMs of undifferentiated developing embryos for prolonged culturing periods. Heterologous DNA is inserted into the subject CICM cells and cell lines so as produce transgenic CICM cell which are introduced into non-human fertilized embryos to produce transgenic chimeric embryos. The transgenic chimeric embryos are transferred into recipient females where they are permitted to develop into transgenic chimeric fetuses. Recipient females give birth to transgenic chimeric animals which are capable of transmitting the heterologous DNA to their progeny. Transgenic CICM cells are also used to produce cloned transgenic embryos, fetuses and offspring.
Patent details
- Publication number
- US 5,994,619
- Filing date
- 1996-12-16
- Grant date
- 1999-11-30
- Assignee
- University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus
- Inventor(s)
- STICE; STEVEN L., CIBELLI; JOSE, ROBL; JAMES, GOLUEKE; PAUL, PONCE DE LEON; F. ABEL, JERRY; D. JOSEPH
- CPC class
- A01K67/0275
Want to file your own patent?
Run your idea through our free scanner β weβll show you which existing patents are conceptually closest, including this one if itβs a match.
Free patentability scanRelated patents in this cluster
- US 5,633,425: Transgenic non-human animals capable of producing heterologous antibodies
- US 5,545,807: Production of antibodies from transgenic animals
- US 5,661,016: Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
- US 6,075,181: Human antibodies derived from immunized xenomice